Prehypertension
Clinical trials for Prehypertension explained in plain language.
Never miss a new study
Get alerted when new Prehypertension trials appear
Sign up with your email to follow new studies for Prehypertension, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New herbal shot aims to tame prehypertension before it becomes a heart risk
Disease control Not yet recruitingThis study tests a liquid herbal supplement called DBPS in 198 adults with prehypertension (blood pressure slightly above normal). Participants will take the supplement or a placebo daily for 4 weeks. The goal is to see if the supplement can lower blood pressure and help prevent …
Matched conditions: PREHYPERTENSION
Sponsor: Eetho Brands, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can black seed capsules tame borderline high blood pressure in women?
Disease control Not yet recruitingThis study tests whether a daily black seed extract supplement (Nisatol®) can help lower blood pressure in women with borderline high readings or a specific nighttime blood pressure pattern. 106 women will take either the supplement or a placebo for 12 weeks. Researchers will mea…
Matched conditions: PREHYPERTENSION
Sponsor: Liaquat University of Medical & Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Fitbit data could help doctors get hypertensive patients moving
Disease control Not yet recruitingThis study will test whether giving primary care doctors easy-to-read reports from patients' Fitbits helps them counsel patients with high blood pressure to be more active. About 330 patients and their doctors will take part. The goal is to see if this simple, low-cost approach c…
Matched conditions: PREHYPERTENSION
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
A daily pill aims to stop overweight from turning into obesity and diabetes
Prevention Not yet recruitingThis phase 3 trial tests whether orforglipron, a daily oral medication, can help overweight adults reduce their risk of developing obesity-related complications such as type 2 diabetes, high blood pressure, and high cholesterol, as well as progression to class 1 obesity. Particip…
Matched conditions: PREHYPERTENSION
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Prevention
Last updated Sep 02, 2026 00:00 UTC